To evaluate the potential mechanisms by which HER-2 overexpression inhibits TGF-β1 mediated gene activation in luminal breast cancer cells, the status of the core TBRI/TBRII/Smad signal transduction pathway in MCF-7 CN and H2 cells was investigated. The gene discussed is TGFB1; the disease is breast cancer.